We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer (BCG/EMDA-MMC)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01442519
First Posted: September 28, 2011
Last Update Posted: September 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of L'Aquila
Information provided by (Responsible Party):
Savino M. Di Stasi, University of Rome Tor Vergata
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)
Publications: